It is not approved for type 2 diabetes management under the Zepbound brand name, though the same active ingredient is marketed as Mounjaro for diabetes treatment
Back Hendershot, CS, Bremmer, MP, Paladino, B, et al (12 Feb 2025) 'Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial', JAMA Network, 82/4, 395-405.Back 'Scientists pioneer two techniques to combat obesity', The Guardian
Current clinical practice considerations emphasize the importance of ophthalmologic screening before initiating GLP-1 therapy in patients with longstanding diabetes and implementing more gradual titration schedules in those with known retinal disease to minimize the risk of early worsening
When you eat, GLP-1 is released in the gut to promote satiety and slow down digestion, helping you feel full longer